Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06883409
What this trial is testing

Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Instituto Nacional de Cancerologia de Mexico 33
Testing effectiveness (Phase 2)Ended earlyNCT03387111
What this trial is testing

QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed

Who this might be right for
Squamous Cell Carcinoma
ImmunityBio, Inc. 4
Testing effectiveness (Phase 2)UnknownNCT01849237
What this trial is testing

Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia

Who this might be right for
Septic ShockNonchemotherapy Drug-induced NeutropeniaNeutropenia After Chemotherapy in Oncohematological Patients+1 more
National Research Center for Hematology, Russia 30
Large-scale testing (Phase 3)Study completedNCT00561119
What this trial is testing

Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Samsung Medical Center 326
Not applicableLooking for participantsNCT06634199
What this trial is testing

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer Stage IIIPDL1 Gene Mutation
Fundación GECP 50
Not applicableLooking for participantsNCT06351475
What this trial is testing

Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Who this might be right for
Peritoneal NeoplasmsHyperthermic Intraperitoneal ChemotherapyIntraoperative Care+2 more
Assistance Publique - Hôpitaux de Paris 140
Large-scale testing (Phase 3)Not Yet RecruitingNCT07328919
What this trial is testing

Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Advanced Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc. 138
Early research (Phase 1)Not Yet RecruitingNCT06490198
What this trial is testing

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

Who this might be right for
CholangiocarcinomaChemotherapy EffectImmunotherapy
Chang Gung Memorial Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04513301
What this trial is testing

Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study

Who this might be right for
Lung Neoplasms
Shanghai Cancer Hospital, China 70
Large-scale testing (Phase 3)Study completedNCT00880971
What this trial is testing

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

Who this might be right for
Thoracic NeoplasmsNon-small Cell Lung Cancer
Chinese Academy of Medical Sciences 394
Testing effectiveness (Phase 2)Ended earlyNCT00087295
What this trial is testing

S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 6
Large-scale testing (Phase 3)Active Not RecruitingNCT06519370
What this trial is testing

FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 350
Testing effectiveness (Phase 2)UnknownNCT05311319
What this trial is testing

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

Who this might be right for
Hepatocarcinoma
Fudan University 70
Testing effectiveness (Phase 2)UnknownNCT04641728
What this trial is testing

Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Saitama Medical University International Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT00001339
What this trial is testing

Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection

Who this might be right for
Adrenal Cortical Carcinoma
National Cancer Institute (NCI) 42
Large-scale testing (Phase 3)Study completedNCT04662801
What this trial is testing

Weight Regain Treatment Post-Bariatric Surgery

Who this might be right for
Obesity, Overweight
Yale University 26
Testing effectiveness (Phase 2)UnknownNCT02202928
What this trial is testing

Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasmsIntestinal Neoplasms+2 more
Shenzhen Hornetcorn Bio-technology Company, LTD 60
Testing effectiveness (Phase 2)Study completedNCT01150630
What this trial is testing

Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 98
Large-scale testing (Phase 3)Not Yet RecruitingNCT06581380
What this trial is testing

JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
JenKem Technology Co., Ltd. 394
Early research (Phase 1)Ended earlyNCT00108108
What this trial is testing

Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy

Who this might be right for
Chronic Lymphocytic Leukemia
Novartis Pharmaceuticals 26
Next Page